# Successful Anesthetic Management Using Remimazolam in a Patient With Spinocerebellar Degeneration Undergoing Pulmonary Resection

**Authors:** Yasuhiro Watanabe, Takamitsu Hayakawa, Hirofumi Okabe

PMC · DOI: 10.7759/cureus.100170 · Cureus · 2025-12-27

## TL;DR

A 79-year-old man with spinocerebellar degeneration successfully underwent lung surgery using remimazolam and careful airway management, avoiding respiratory complications.

## Contribution

This case demonstrates the successful use of remimazolam in anesthetic management for a patient with spinocerebellar degeneration undergoing pulmonary resection.

## Key findings

- The use of remimazolam and a supraglottic airway minimized respiratory risks during anesthesia emergence.
- The patient remained conscious and free from respiratory depression or neurological symptom exacerbation post-surgery.
- Careful anesthetic and airway management enabled a successful outcome in a high-risk patient.

## Abstract

Spinocerebellar degeneration (SCD) comprises a broad range of neurodegenerative disorders mainly characterized by cerebellar ataxia, and the prevention of perioperative respiratory complications is of great importance in patients with cerebellar ataxia. Clinical papers addressing anesthetic management using remimazolam in patients with SCD, specifically those undergoing pulmonary resection, are limited. A 79-year-old man with cortical cerebellar atrophy, a sporadic adult-onset SCD, was admitted for pulmonary resection for primary lung adenocarcinoma. He has experienced chronic aspiration caused by dysphagia, placing him at an increased risk for perioperative respiratory complications. Video-assisted right S6 segmentectomy was performed under general-epidural anesthesia using remimazolam, remifentanil, and local anesthetics. During emergence from anesthesia and tracheal extubation, a supraglottic airway was inserted while the double-lumen tube remained in place, after which the tube was removed under deep anesthesia. Subsequently, continuous infusion of remimazolam and remifentanil was terminated, and remimazolam was antagonized using flumazenil. After confirmation of spontaneous breathing and response to verbal commands, the supraglottic airway was removed without triggering the cough reflex or laryngospasm. The patient was fully conscious and did not experience re-sedation or respiratory depression. Furthermore, he had a good postoperative course and was discharged without respiratory complications or exacerbation of neurological symptoms. In conclusion, anesthetic management using remimazolam alongside careful airway management contributed to the successful management of a patient with SCD undergoing pulmonary resection. For a patient exhibiting cerebellar ataxia, remimazolam can be a useful anesthetic agent.

## Linked entities

- **Chemicals:** remimazolam (PubChem CID 9867812), remifentanil (PubChem CID 60815), flumazenil (PubChem CID 3373)
- **Diseases:** spinocerebellar degeneration (MONDO:0000437), lung adenocarcinoma (MONDO:0005061)

## Full-text entities

- **Diseases:** laryngospasm (MESH:D007826), SCD (MESH:D013132), cough (MESH:D003371), cortical cerebellar atrophy (MESH:D002526), cerebellar ataxia (MESH:D002524), lung adenocarcinoma (MESH:D000077192), neurodegenerative disorders (MESH:D019636), respiratory depression (MESH:D012131), dysphagia (MESH:D003680)
- **Chemicals:** Remimazolam (MESH:C522201), flumazenil (MESH:D005442), remifentanil (MESH:D000077208)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12833793/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12833793/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12833793/full.md

---
Source: https://tomesphere.com/paper/PMC12833793